Teladoc Health (TDOC) Operating Income (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Operating Income data on file, last reported at -$61.8 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Income rose 48.79% year-over-year to -$61.8 million; the trailing twelve-month figure through Mar 2026 stood at -$204.1 million (up 80.64% YoY), and the FY2025 full-year result was -$263.0 million, up 74.24% from the prior year.
• Operating Income fell to -$61.8 million in Q1 2026, from -$36.0 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$35.1 million in Q4 2023 to a low of -$6.7 billion in Q1 2022.
• A 5-year average of -$896.9 million and a median of -$71.6 million in 2023 frame the typical range for Operating Income.
• Across the five-year window, Operating Income plunged 9109.86% in 2022 and jumped 99.08% in 2023, its largest moves.
• Tracing TDOC's Operating Income over 5 years: stood at -$3.8 billion in 2022, then jumped by 99.08% to -$35.1 million in 2023, then tumbled by 37.44% to -$48.2 million in 2024, then increased by 25.34% to -$36.0 million in 2025, then plunged by 71.59% to -$61.8 million in 2026.
• Business Quant data shows TDOC's Operating Income at -$61.8 million in Q1 2026, -$36.0 million in Q4 2025, and -$52.0 million in Q3 2025.